You have 9 free searches left this month | for more free features.

B3GALNT2

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Oct 5, 2023

Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)

Not yet recruiting
  • Pneumococcal Vaccines
  • IVT PCV-25 Formulation A
  • +3 more
  • Vancouver, British Columbia, Canada
  • +3 more
Oct 10, 2023

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Axicabtagene Ciloleucel
  • +10 more
  • (no location specified)
Jan 13, 2023

Anesthesia Trial in Halifax, Montréal (memsorb)

Recruiting
  • Anesthesia
  • memsorb
  • Halifax, Nova Scotia, Canada
  • +1 more
Nov 18, 2022

Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • CD19-targeted chimeric antigen receptor T-cell
  • Kaohsiung, Taiwan
  • +2 more
Oct 25, 2022

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Recruiting
  • Acute Lymphoblastic Leukemia
  • Large B-cell Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Contraception, Prevention of Sexually Transmitted Infections Trial in Los Angeles (Control Latex Condom C, Polyurethane Condom

Completed
  • Contraception
  • Prevention of Sexually Transmitted Infections
  • Control Latex Condom C, Polyurethane Condom A, Polyurethane Condom B
  • Los Angeles, California
    Essential Access Health
Feb 28, 2023

Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)

Not yet recruiting
  • Malaria,Falciparum
  • MSP3-CRM-Vac4All/ Alhydrogel®
  • Anti-Rabies Vaccine
  • Bamako, Mali
    Malaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023

Psoriasis Trial in Worldwide (Secikinumab)

Active, not recruiting
  • Psoriasis
  • Adrogué, Buenos Aires, Argentina
  • +80 more
Oct 14, 2022

COVID-19 Trial in Adelaide (Advax-CpG55.2 adjuvanted recombinant spike protein)

Recruiting
  • COVID-19
  • Advax-CpG55.2 adjuvanted recombinant spike protein
  • Adelaide, South Australia, Australia
    ARASMI
Aug 15, 2022

Advanced Solid Tumors Trial in Australia, Korea, Republic of, Thailand (YBL-006)

Active, not recruiting
  • Advanced Solid Tumors
  • Macquarie, New South Wales, Australia
  • +6 more
Dec 1, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Virus Diseases Trial in London (ConM SOSIP 50 ug and ConS UFO 50 ug, Mos3.1 100 ug, Mos3.2 100 ug)

Active, not recruiting
  • Virus Diseases
  • ConM SOSIP 50 ug and ConS UFO 50 ug
  • +4 more
  • London, Please Select..., United Kingdom
    NIHR Imperial Clinical Research Facility
Jul 25, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 22, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +2 more
  • Brookvale, New South Wales, Australia
  • +25 more
Nov 13, 2023

Amyotrophic Lateral Sclerosis Trial in Fredericton, Montréal (Reldesemtiv)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Fredericton, New Brunswick, Canada
  • +1 more
Aug 9, 2022

DLBCL, Not Otherwise Specified, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Seattle

Terminated
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • +5 more
  • Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 1, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,

Completed
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +8 more
  • PI3K inhibitor BKM120
  • +3 more
  • Atlanta, Georgia
  • +1 more
Jun 27, 2022

Abdominal Aortic Aneurysm (AAA), No Abdominal Aortic Aneurysm (Non-AAA) Trial in Saint Louis (AAA Group (Aim 3A), Non-AAA Group,

Recruiting
  • Abdominal Aortic Aneurysm (AAA)
  • No Abdominal Aortic Aneurysm (Non-AAA)
  • AAA Group (Aim 3A)
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 11, 2022

Exercise-Induced Lactic Acidemia Trial in Saskatoon (Beta-alanine, Maltodextrin)

Recruiting
  • Exercise-Induced Lactic Acidemia
  • Beta-alanine
  • Maltodextrin
  • Saskatoon, Saskatchewan, Canada
    University of Saskatchewan
Mar 14, 2023

Covid19 Trial in Miami (BNT162b2 vaccine, JNJ-78436735 Vaccine)

Active, not recruiting
  • Covid19
  • BNT162b2 vaccine
  • JNJ-78436735 Vaccine
  • Miami, Florida
    University of Miami
Aug 1, 2022